APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genital Herpes Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Genital Herpes Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchGenital Herpes Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Genital Herpes Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Genital Herpes Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genital Herpes Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genital Herpes Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Genital Herpes Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genital Herpes Vaccine include GSK, Changsheng Biotechnology, Merck, Beike Bio and BioNTech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genital Herpes Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genital Herpes Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genital Herpes Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genital Herpes Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Genital Herpes Vaccine Segment by Company

GSK

Changsheng Biotechnology

Merck

Beike Bio

BioNTech

Genital Herpes Vaccine Segment by Type

Zoster Vaccine Live

Recombinant Zoster Vaccine

Genital Herpes Vaccine Segment by Application

Male

Female

Genital Herpes Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genital Herpes Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genital Herpes Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genital Herpes Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genital Herpes Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genital Herpes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Genital Herpes Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Genital Herpes Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Genital Herpes Vaccine Industry Trends Table 2. Genital Herpes Vaccine Industry Drivers Table 3. Genital Herpes Vaccine Industry Opportunities and Challenges Table 4. Genital Herpes Vaccine Industry Restraints Table 5. Global Genital Herpes Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Genital Herpes Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Genital Herpes Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Genital Herpes Vaccine Sales Market Share by Manufacturers Table 9. Global Genital Herpes Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Genital Herpes Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Genital Herpes Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Genital Herpes Vaccine Manufacturers, Product Type & Application Table 13. Global Genital Herpes Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Genital Herpes Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Zoster Vaccine Live Table 17. Major Manufacturers of Recombinant Zoster Vaccine Table 18. Global Genital Herpes Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Genital Herpes Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Genital Herpes Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Genital Herpes Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Genital Herpes Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Genital Herpes Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Genital Herpes Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Male Table 29. Major Manufacturers of Female Table 30. Global Genital Herpes Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Genital Herpes Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Genital Herpes Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Genital Herpes Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Genital Herpes Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Genital Herpes Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Genital Herpes Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Genital Herpes Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Genital Herpes Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Genital Herpes Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Genital Herpes Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Genital Herpes Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Genital Herpes Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Genital Herpes Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Genital Herpes Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Genital Herpes Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Genital Herpes Vaccine Revenue Market Share by Region (2027-2032) Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Genital Herpes Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. GSK Genital Herpes Vaccine Product Portfolio Table 66. GSK Recent Development Table 67. Changsheng Biotechnology Company Information Table 68. Changsheng Biotechnology Business Overview Table 69. Changsheng Biotechnology Genital Herpes Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio Table 71. Changsheng Biotechnology Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Genital Herpes Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Genital Herpes Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Beike Bio Company Information Table 78. Beike Bio Business Overview Table 79. Beike Bio Genital Herpes Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Beike Bio Genital Herpes Vaccine Product Portfolio Table 81. Beike Bio Recent Development Table 82. BioNTech Company Information Table 83. BioNTech Business Overview Table 84. BioNTech Genital Herpes Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. BioNTech Genital Herpes Vaccine Product Portfolio Table 86. BioNTech Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Genital Herpes Vaccine Distributors List Table 90. Genital Herpes Vaccine Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Genital Herpes Vaccine Product Image Figure 2. Global Genital Herpes Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genital Herpes Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Genital Herpes Vaccine Sales (2021-2032) & (k units) Figure 5. Global Genital Herpes Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Genital Herpes Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Zoster Vaccine Live Image Figure 9. Recombinant Zoster Vaccine Image Figure 10. Global Genital Herpes Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Genital Herpes Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Genital Herpes Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Genital Herpes Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Genital Herpes Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Male Image Figure 17. Female Image Figure 18. Global Genital Herpes Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Genital Herpes Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Genital Herpes Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Genital Herpes Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Genital Herpes Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Genital Herpes Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Genital Herpes Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Genital Herpes Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Genital Herpes Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Genital Herpes Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Genital Herpes Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Genital Herpes Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Genital Herpes Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Genital Herpes Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Zoster Vaccine Live
  • Recombinant Zoster Vaccine
Applications
  • Male
  • Female
Companies covered
  • GSK
  • Changsheng Biotechnology
  • Merck
  • Beike Bio
  • BioNTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genital Herpes Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genital Herpes Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Genital Herpes Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Genital Herpes Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Genital Herpes Vaccine Market Dynamics
  1. 2.1 Genital Herpes Vaccine Industry Trends
  2. 2.2 Genital Herpes Vaccine Industry Drivers
  3. 2.3 Genital Herpes Vaccine Industry Opportunities and Challenges
  4. 2.4 Genital Herpes Vaccine Industry Restraints
3 Genital Herpes Vaccine Market by Manufacturers
  1. 3.1 Global Genital Herpes Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Genital Herpes Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Genital Herpes Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Genital Herpes Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genital Herpes Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Genital Herpes Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Genital Herpes Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genital Herpes Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genital Herpes Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genital Herpes Vaccine Tier 1, Tier 2, and Tier 3
4 Genital Herpes Vaccine Market by Type
  1. 4.1 Genital Herpes Vaccine Type Introduction
  2. 4.1.1 Zoster Vaccine Live
  3. 4.1.2 Recombinant Zoster Vaccine
  4. 4.2 Global Genital Herpes Vaccine Sales by Type
  5. 4.2.1 Global Genital Herpes Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genital Herpes Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Genital Herpes Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Genital Herpes Vaccine Revenue by Type
  9. 4.3.1 Global Genital Herpes Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Genital Herpes Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2032)
5 Genital Herpes Vaccine Market by Application
  1. 5.1 Genital Herpes Vaccine Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Genital Herpes Vaccine Sales by Application
  5. 5.2.1 Global Genital Herpes Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Genital Herpes Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Genital Herpes Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Genital Herpes Vaccine Revenue by Application
  9. 5.3.1 Global Genital Herpes Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Genital Herpes Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2032)
6 Global Genital Herpes Vaccine Sales by Region
  1. 6.1 Global Genital Herpes Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genital Herpes Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Genital Herpes Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Genital Herpes Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Genital Herpes Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Genital Herpes Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Genital Herpes Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Genital Herpes Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Genital Herpes Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Genital Herpes Vaccine Revenue by Region
  1. 7.1 Global Genital Herpes Vaccine Revenue by Region
  2. 7.1.1 Global Genital Herpes Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Genital Herpes Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Genital Herpes Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Genital Herpes Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Genital Herpes Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Genital Herpes Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Genital Herpes Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Genital Herpes Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Genital Herpes Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Genital Herpes Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Genital Herpes Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Changsheng Biotechnology
  8. 8.2.1 Changsheng Biotechnology Company Information
  9. 8.2.2 Changsheng Biotechnology Business Overview
  10. 8.2.3 Changsheng Biotechnology Genital Herpes Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio
  12. 8.2.5 Changsheng Biotechnology Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Genital Herpes Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Genital Herpes Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Beike Bio
  20. 8.4.1 Beike Bio Company Information
  21. 8.4.2 Beike Bio Business Overview
  22. 8.4.3 Beike Bio Genital Herpes Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beike Bio Genital Herpes Vaccine Product Portfolio
  24. 8.4.5 Beike Bio Recent Developments
  25. 8.5 BioNTech
  26. 8.5.1 BioNTech Company Information
  27. 8.5.2 BioNTech Business Overview
  28. 8.5.3 BioNTech Genital Herpes Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioNTech Genital Herpes Vaccine Product Portfolio
  30. 8.5.5 BioNTech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genital Herpes Vaccine Value Chain Analysis
  2. 9.1.1 Genital Herpes Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genital Herpes Vaccine Production Mode & Process
  6. 9.2 Genital Herpes Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genital Herpes Vaccine Distributors
  9. 9.2.3 Genital Herpes Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst